A USA company, Abbott, has received authorization from the U.S. Food and Drug Administration for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes.
What makes this test so different is where it can be used: outside the four walls of a traditional hospital such as in the physicians’ office or urgent care clinics.
The test runs on a lightweight box (6.6 pounds and the size of a small toaster) that can sit in a variety of locations.
Because of its small size, it can be used in more non-traditional places where people can have their results in a matter of minutes.
They are ramping up production to deliver 50,000 ID NOW COVID-19 tests per day, beginning next week, to the U.S. healthcare system.
“Through the incredible work of teams across Abbott, we expect to deliver 50,000 COVID-19 tests per day to healthcare professionals on the front lines, where testing capabilities are needed most,” said Chris Scoggins, senior vice president, Rapid Diagnostics, Abbott.
Chinese President Xi Jinping said the world is facing "serious challenges" and urged the BRICS…
USA Coach Katie Schoepfer looks to strike perfection ahead of Saturday's clash with Nigeria at…
The Governor of the Central Bank of Nigeria (CBN), Olayemi Cardoso, has said the bank…
The Norwich City first team announced on Wednesday that Jack Wilshere, a former Arsenal star,…
President Tinubu discharged five, approved reassignment of 10 ministers to new portfolios, nominated seven send…
Chairman of Senate ad hoc committee has revived activities at Ajaokuta Steel Company Limited and…